Aelis Farma SA
PAR:AELIS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Aelis Farma SA
PAR:AELIS
|
FR |
|
A
|
Asefa PCL
SET:ASEFA
|
TH |
|
iSelect Ltd
ASX:ISU
|
AU |
|
P
|
Pharmesis International Ltd
SGX:BFK
|
CN |
|
Pendragon PLC
LSE:PDG
|
UK |
|
T
|
TTET Union Corp
TWSE:1232
|
TW |
|
InVision AG
XETRA:IVX
|
DE |
|
D
|
Devsisters Corp
KOSDAQ:194480
|
KR |
|
H
|
HLS Therapeutics Inc
OTC:HLTRF
|
CA |
|
S
|
State Bank of India
BSE:500112
|
IN |
|
Yingkou Jinchen Machinery Co Ltd
SSE:603396
|
CN |
|
S
|
SKK Holdings Ltd
NASDAQ:SKK
|
SG |
|
F
|
Fasoo Co Ltd
KOSDAQ:150900
|
KR |
|
Weed Inc
OTC:BUDZ
|
US |
|
A
|
Arrowroot Acquisition Corp
NASDAQ:AILE
|
US |
|
N
|
Northern Textiles And Garments JSC
VN:TET
|
VN |
|
West Holdings Corp
TSE:1407
|
JP |
|
Boeing Co
NYSE:BA
|
US |
|
Y
|
Yantai Eddie Precision Machinery Co Ltd
SSE:603638
|
CN |
|
Adolfo Dominguez SA
MAD:ADZ
|
ES |
|
BBR Holdings (S) Ltd
SGX:KJ5
|
SG |
|
D
|
Doosan Robotics Inc
KRX:454910
|
KR |
Bankruptcy Probability
Aelis Farma SA's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Aelis Farma SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
A
|
Aelis Farma SA
PAR:AELIS
|
18.3m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
367.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
189.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
172.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
42.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
67.1B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Aelis Farma SA's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Aelis Farma SA has total debt of 4.5m EUR. This includes both short-term (4k EUR) and long-term (4.5m EUR) debt.
You can find a full breakdown on its Balance Sheet.
